The Wegovy obesity drug maker on Wednesday announced plans to trim 11.5% of its workforce.
Get this delivered to your inbox, and more info about our products and services.
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
Ozempic-maker Novo Nordisk to cut 9,000 jobs
Wegovy maker Novo Nordisk to slash thousands of jobs
Novo Nordisk despedirá a 9.000 empleados, el 11% de la plantilla, ante el aumento de la competencia en los tratamientos de obesidad
Novo Nordisk taglia 9 mila posti di lavoro: cosa sta succedendo al colosso dei farmaci anti-obesità
Crisi Ozempic: Novo Nordisk taglia 9mila posti di lavoro dopo crollo degli utili
Wettbewerb um Abnehmspritzen: Novo Nordisk streicht 9000 Stellen
Novo Nordisk, which produces Wegovy and Ozempic, said roughly 9,000 roles would be cut, with 5,000 of these reductions expected…
Novo Nordisk CEO Mike Doustdar discusses the pharma giant's Q4 reporting, uptake of obesity drugs and how he plans to navigate…
The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and…
The bank downgraded the Danish pharmaceutical giant to neutral from buy and decreased its price target.
Analysts raced to cut price targets on an already struggeling Novo Nordisk stock following disappointing trial results for its…
The Danish firm, which also produces Wegovy, has warned of increased pressure from "knock-off" drugs.
